Prostate Cancer Recurrent: Clinical Trials

1 trial for Prostate Cancer Recurrent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Prostate Cancer Recurrent: new trials by email Literature Review of Prostate Cancer Recurrent trials Research Report on Prostate Cancer Recurrent

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Firmagon (Degarelix) Intermittent Therapy
degarelix - Prostate Cancer Recurrent
Phase 4TerminatedCanadian Urology Research Consortium1442012-01-012019-09-23

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1)

Sponsors

Canadian Urology Research Consortium (1)

Countries

Canada (1)

Top investigators

Laurence Klotz, MD (1)